Latest News & Features
Big Pharma
Proposals include new regulatory protection periods for innovative drugs | Changes are aimed at improving patient access to therapeutics and boosting the EU pharma industry. 27 April 2023
article
First chair litigator served six years at the US Patent and Trademark Office. 25 April 2023
Big Pharma
Judge rejects notion that tribunal acted unfairly in royalties dispute with Salix | Indian firm wanted payments on sales of antibiotic | Appeal brought under act with ‘high hurdle to surmount’. 25 April 2023
Americas
New Jersey judge denies motion to stay antitrust action regarding blockbuster cancer drug | Defendants had argued litigation would be unnecessary and costly. 25 April 2023
Big Pharma
Canadian firm alleges infringement of patent directed to cosmetic and pharmaceutical formulations | Pharma giant declined a licensing agreement. 20 April 2023
Big Pharma
Court affirms decision that two Otezla patents are not invalid | Apremilast generics set for 2028 release. 20 April 2023
Americas
Petition to review invalidation of Gilenya patent denied | Novartis challenged decision resulting from a change in judicial panel. 18 April 2023
Americas
Precedential decision upholds lower court’s earlier finding | Patent at heart of the dispute covers treatment patch for Parkinson’s. 13 April 2023
Americas
Biotech fails to convince Federal Circuit to overturn PTAB finding | Invalidation of patent related to “Non-liposomal systems for nucleic acid delivery”. 12 April 2023
Americas
Feud concerned the ownership of six immunotherapy patents |
Cancer centre claimed that it was unfairly deprived of royalties. 11 April 2023